Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

KHN’s ‘What the Health?’: A health-heavy State of the Union

Russia's attacks on Ukraine took the headlines for President Joe Biden's first official State of the Union address, but Biden made a point to highlight several of the administration's high-priority health issues, including covid, mental health, nursing home regulation, and ailments among military personnel from toxic burn pits.

3 Mar 2022

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Researchers engineered a mutant ACE2 decoy that effectively protected human lung epithelia from SARS-CoV-2 infection by competitively binding to its spike protein.

3 Mar 2022

Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

Researchers tested the safety and efficacy of 600 mg oral dose of nitazoxanide in mild or moderately ill COVID-19 patients.

3 Mar 2022

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

Researchers conduct a multi-center study involving hospitalized COVID-19 patients to gather information on the rationale use of convalescent plasma.

3 Mar 2022

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

Researchers assess the efficacy of 8G3, a B-cell neutralizing antibody against SARS-CoV-2 variants, including the most recent Omicron variant.

3 Mar 2022

Incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease patients

A new study assesses breakthrough SARS-CoV-2 infections in vaccinated CLD patients with cirrhosis as compared to CLD patients without cirrhosis.

3 Mar 2022

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

A new study has focused on developing a novel anti-SARS-CoV-2 therapy using HTA directed against the human host DEAD-box RNA helicase.

3 Mar 2022

Study establishes that a low dose SARS-CoV-2 infection increases risk of pneumococcal coinfection

A new study published on the bioRxiv* preprint server has evaluated bacterial susceptibility during SARS-CoV-2 infection.

3 Mar 2022

$The benefits of using fractional doses of COVID-19 vaccines$

The benefits of using fractional doses of COVID-19 vaccines

A new study published in PNAS assessed the benefits of using fractional doses for curbing the current COVID-19 pandemic.

3 Mar 2022

First dose SARS-CoV-2 vaccination coverage among younger children in America

Researchers recently investigated the differences in first dose coverage of coronavirus disease 2019 vaccination among children aged five to 11 years in the United States.

3 Mar 2022

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Researchers found that infection with one Omicron sub-lineage of SARS-CoV-2 induces strong protection against reinfection with the other Omicron sub-lineage.

3 Mar 2022

Additional doses of covid-19 vaccine recommended for immunocompromised patients

Additional doses of covid-19 vaccine are recommended for immunocompromised patients, especially for organ transplant recipients who are least able to make antibodies to fight off coronavirus, say experts in The BMJ today.

3 Mar 2022

Study explores coronavirus surveillance in bats from Argentina

In a new study, researchers monitored the circulation of coronaviruses in bats from the central and northern provinces of Argentina.

3 Mar 2022

WHO experts suggest antiviral drug for patients with non-severe covid-19 at highest risk of hospitalization

The antiviral drug molnupiravir is conditionally recommended for patients with non-severe covid-19 who are at highest risk of hospitalization, says a WHO Guideline Development Group of international experts in The BMJ today.

3 Mar 2022

Multigranular and visualization approach precisely predicts SARS-CoV-2 outcomes

In a new study, researchers presented the Multiscale potential of heat-diffusion for affinity-based trajectory embedding approach that identified multimodal signatures of SARS-CoV-2shut.

3 Mar 2022

Identifying and managing drug-drug interactions key to the safe use of nirmatrelvir–ritonavir in COVID-19 treatment

Researchers compiled evidence-based recommendations in consultation with European and North American clinicians and pharmacologists for recognizing and managing drug-drug interactions with nirmatrelvir–ritonavir.

3 Mar 2022

Assessing the potential of IFNa subtypes in suppressing SARS-CoV-2

A recent study analyzes IFNa subtypes for their therapeutic potential against SARS-CoV-2 and identified the underlying immune signatures and mechanisms.

3 Mar 2022

A model for predicting the evolution of the Omicron wave

Scientists forecast the temporal evolution of the Omicron wave according to a susceptible-infectious-recovered/removed epidemic compartment model.

3 Mar 2022

Scientists find no connection between pandemic chilblains and SARS-CoV-2 infection

A recent study provides a better understanding of whether SARS-CoV-2 infection is linked with the occurrence of chilblains.

3 Mar 2022

Research uncovers a new molecular interaction mechanism for SARS-CoV2

The virus causing the current COVID-19 pandemic is the SARS-CoV-2. Soon after the pandemic outbreak in 2019, the ACE-2 protein, which is present on some of our cells´ surface, was identified as the receptor facilitating host cell viral entry.

3 Mar 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

KHN’s ‘What the Health?’: A health-heavy State of the Union

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

Incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease patients

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

Study establishes that a low dose SARS-CoV-2 infection increases risk of pneumococcal coinfection

The benefits of using fractional doses of COVID-19 vaccines

First dose SARS-CoV-2 vaccination coverage among younger children in America

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Additional doses of covid-19 vaccine recommended for immunocompromised patients

Study explores coronavirus surveillance in bats from Argentina

WHO experts suggest antiviral drug for patients with non-severe covid-19 at highest risk of hospitalization

Multigranular and visualization approach precisely predicts SARS-CoV-2 outcomes

Identifying and managing drug-drug interactions key to the safe use of nirmatrelvir–ritonavir in COVID-19 treatment

Assessing the potential of IFNa subtypes in suppressing SARS-CoV-2

A model for predicting the evolution of the Omicron wave

Scientists find no connection between pandemic chilblains and SARS-CoV-2 infection

Research uncovers a new molecular interaction mechanism for SARS-CoV2

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in